Patent number: 6635630
Abstract: Compound represented by the structural formula
or a pharmaceutically acceptable salt thereof, wherein
Ar1 and Ar2 are optionally substituted heteroaryl or optionally substituted phenyl;
X1 is —O—, —S—, —SO—, —SO2—, —NR12—, —NCOR12— or —NR12SO2R15;
is selected from the group consisting of
X2 is —O—, —S— or —NR5—;
Y is ═O, ═S or ═NR11;
Y1 is H, C1-C6 alkyl, —NR17R13, —SCH3, R19-aryl(CH2)n6—, R19-heteroaryl-(CH2)n6—, —(CH2)n6—heterocycloalkyl, —(C1-C3)alkyl-NH—C(O)O(C1-C6)alkyl or —NHC(O)R15;
R5 is H or —(CH2)n1—G, wherein n1 is 0-5, G is H, —CF3, —CHF2, —CH2F, —OH, —O—(C1-C6 alkyl), —SO2R13, —O—(C3-C8 cycloalkyl), —NR13R14, —SO2NR13R14, —NR13SO2R15, —NR13COR12, —NR12(CONR13
Type:
Grant
Filed:
June 6, 2002
Date of Patent:
October 21, 2003
Assignee:
Schering Corporation
Inventors:
Neng-Yang Shih, Ho-Jane Shue, Gregory A. Reichard, Sunil Paliwal, David J. Blythin, John J. Piwinski, Dong Xiao, Xiao Chen
Patent number: 6436928
Abstract: A compound represented by the structural formula
or a pharmaceutically acceptable salt thereof, wherein
Ar1 and Ar2 are optionally substituted heteroaryl or optionally substituted phenyl;
X1 is —O—, —SO0-2—, —NR12—, —NCOR12— or —NR12SO2R15;
is
X2 is —O—, —S— or optionally substituted nitrogen;
Y is ═O, ═S or ═NR11;
Y1 is H, alkyl, —NR17R13, —SCH3, R19-aryl(CH2)n6—, R19-heteroaryl-(CH2)n6—, —(CH2)n6-heterocycloalkyl, -alkyl-NH—C(O)O-alkyl or —NHC(O)R15;
R1, R2, R3 and R7 are H, alkyl, OH-alkyl, cycloalkyl, —CHF2, —CH2F or —CF3; or R1 and R2 form an alkylene ring; or R1 and R2 together are ═O;
R6 is H, alkyl, —OR13 or —SR12;
and the remaining variables are as defined in the specification, is disclosed, as well as a pharmaceutical compositions comprising said compound, methods of
Type:
Grant
Filed:
December 14, 2000
Date of Patent:
August 20, 2002
Assignee:
Schering Corporation
Inventors:
Neng-Yang Shih, Ho-Jane Shue, Gregory A. Reichard, Sunil Paliwal, David J. Blythin, John J. Piwinski, Dong Xiao, Xiao Chen
